The scientist’s investigation covers issues in Colistin, Antibiotics, Pharmacokinetics, Microbiology and Antibacterial agent. His Colistin study incorporates themes from Pseudomonas aeruginosa, Pharmacodynamics, Pharmacology, Polymyxin and Drug resistance. The Antibiotics study which covers Intensive care medicine that intersects with Susceptibility testing, Treatment outcome, Cefepime and Meningitis.
His work deals with themes such as Anesthesia, Urine, Nephrotoxicity and Renal function, which intersect with Pharmacokinetics. The study of Microbiology is intertwined with the study of Acinetobacter baumannii in a number of ways. His Antibacterial agent research is multidisciplinary, relying on both High-performance liquid chromatography, Chromatography, Klebsiella pneumoniae and Antimicrobial pharmacodynamics.
Roger L. Nation spends much of his time researching Pharmacokinetics, Colistin, Pharmacology, Microbiology and Antibiotics. As a member of one scientific family, Roger L. Nation mostly works in the field of Pharmacokinetics, focusing on Renal function and, on occasion, Creatinine. His Colistin study combines topics in areas such as Antibacterial agent, Nephrotoxicity, Polymyxin B, Dosing and Polymyxin.
His studies in Pharmacology integrate themes in fields like Regimen, Kidney and Toxicity. The Microbiology study combines topics in areas such as Pseudomonas aeruginosa, Acinetobacter baumannii and Lipopolysaccharide. His Antibiotics research incorporates elements of Combination therapy and Intensive care medicine.
Roger L. Nation mostly deals with Polymyxin, Polymyxin B, Pharmacokinetics, Colistin and Microbiology. His work in Polymyxin addresses issues such as Nephrotoxicity, which are connected to fields such as Acute kidney injury and Side effect. Roger L. Nation has included themes like Urine, Klebsiella pneumoniae, MCR-1 and Dosing in his Polymyxin B study.
His Pharmacokinetics research is classified as research in Pharmacology. His study in the field of Colistimethate is also linked to topics like In patient. The concepts of his Microbiology study are interwoven with issues in Pseudomonas aeruginosa and Acinetobacter baumannii.
His primary areas of study are Colistin, Polymyxin, Microbiology, Polymyxin B and Antibiotics. His Colistin study integrates concerns from other disciplines, such as Acute kidney injury and Pharmacokinetics, Pharmacology. His Pharmacokinetics research incorporates themes from Anesthesia, Critically ill and Liter.
His Microbiology research includes themes of Pseudomonas aeruginosa, Acinetobacter baumannii and Gram-negative bacteria. His study in Polymyxin B is interdisciplinary in nature, drawing from both Nephrotoxicity and Dosing. His work carried out in the field of Antibiotic resistance brings together such families of science as Multiple drug resistance and Acinetobacter.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
Jian Li;Roger Leigh Nation;John D Turnidge;Robert W Milne.
Lancet Infectious Diseases (2006)
Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients
Samira Garonzik;Jian Li;Jian Li;Visanu Thamlikitkul;David Paterson.
Antimicrobial Agents and Chemotherapy (2011)
Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review
Alexandre Prehn Zavascki;Alexandre Prehn Zavascki;Luciano Zubaran Goldani;Jian Li;Roger L. Nation.
Journal of Antimicrobial Chemotherapy (2007)
Colistin Resistance in Acinetobacter baumannii Is Mediated by Complete Loss of Lipopolysaccharide Production
Jennifer H Moffatt;Marina Harper;Marina Harper;Paul F Harrison;John Df Hale.
Antimicrobial Agents and Chemotherapy (2010)
Heteroresistance to Colistin in Multidrug-Resistant Acinetobacter baumannii
Jian Li;Craig Robert Rayner;Roger Leigh Nation;Roxanne J Owen.
Antimicrobial Agents and Chemotherapy (2006)
Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria
Jian Li;Roger Leigh Nation;Robert L Milne;John D Turnidge.
International Journal of Antimicrobial Agents (2005)
Structure—Activity Relationships of Polymyxin Antibiotics
Tony Velkov;Philip Thompson;Roger Leigh Nation;Jian Li.
Journal of Medicinal Chemistry (2010)
Colistin in the 21st century.
Roger Leigh Nation;Jian Li.
Current Opinion in Infectious Diseases (2009)
Colistin Methanesulfonate Is an Inactive Prodrug of Colistin against Pseudomonas aeruginosa
Phillip John Bergen;Jian Li;Craig Robert Rayner;Roger Leigh Nation.
Antimicrobial Agents and Chemotherapy (2006)
Pharmacology of polymyxins: new insights into an 'old' class of antibiotics.
Tony Velkov;Kade Douglas Roberts;Roger Leigh Nation;Philip Thompson.
Future Microbiology (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: